The modest reduction in cancer cell proliferation by PBP, demonstrating that peptide alone was an insufficient treatment of cancer, is likely the consequence of inhibition of prohibitin rather than any manifestation of toxicity [19,25]. The gene discussed is PHB1; the disease is cancer.